Fulgent Genetics
FLGT
214 hedge funds and large institutions have $515M invested in Fulgent Genetics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 85 reducing their positions, and 30 closing their positions.
122% more call options, than puts
Call options by funds: $12.1M | Put options by funds: $5.46M
22% more capital invested
Capital invested by funds: $422M → $515M (+$92.6M)
1.02% more ownership
Funds ownership: 45.8% → 46.82% (+1%)
3% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 30
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less funds holding
Funds holding: 215 → 214 (-1)
47% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 85
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$11.4M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.73M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$6.53M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.79M |
| 5 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$3.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$8.4M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.53M |
| 3 |
Morgan Stanley
New York
|
-$2.87M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.16M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
-$1.61M |
FLGT Hedge Fund Activity: Q2 2023 in Review
214 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2023, worth a combined $515M — up 22% from $422M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FLGT positions and 30 closed out — a net gain of 1 holder — while 45 added to existing stakes and 85 trimmed.
The largest buyer was Divisadero Street Capital Management, adding an estimated $11.4M. The largest seller was Invesco, cutting an estimated $8.4M.
- 214 institutional investors held Fulgent Genetics (FLGT) as of Q2 2023, down from 215 in Q1 2023.
- Funds reported $515M of Fulgent Genetics stock for Q2 2023, up 22% quarter-over-quarter.
- 31 funds opened new Fulgent Genetics positions in Q2 2023 and 30 closed out, a net change of +1 holder.
- The largest Fulgent Genetics buyer in Q2 2023 was Divisadero Street Capital Management, an estimated $11.4M added.
- The largest Fulgent Genetics seller in Q2 2023 was Invesco, an estimated $8.4M sold.
Based on aggregated 13F filings for Q2 2023.